Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
Status:
Completed
Trial end date:
2013-07-31
Target enrollment:
Participant gender:
Summary
A Multicenter, Randomized, Double-blind Phase Ⅲ Study of Cyclosporine Ophthalmic Soution
Group and Cyclosporine Ophthalmic Suspension Group 12 Weeks After Treatment in Moderate to
Severe Dry Eye Disease